Preview
Sign-in for full Details 
Sign-in free and Explore the Exciting World of BiomedExperts:
- Over 1.500.000 Profiles
- More than 1.800 Organizations worldwide
- State of the Art Network Visualizations
- Manage your own Profile
- Locate Experts in your Country/Region
- Locate Experts in your 1. and 2. Level Network
- Connect to Experts Worldwide
NetworkView
Earl Kern
This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers
together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles
free of charge to researchers worldwide.
Research Profile (preview)
Chemicals & Drugs
Living Beings
Physiology
Procedures
Disorders
Anatomy
Concepts & Ideas
Sign-in to see full Profile
Network (preview)
26
Hartline, Caroll
24
Drach, John
24
Zemlicka, Jiri
22
Prichard, Mark
20
Keith, Kathy
20
Quenelle, Debra
19
Hostetler, Karl
18
Beadle, James
13
Cheng, Yung-Chi
12
Harden, Emma
11
Bidanset, Deborah
9
Collins, Deborah
9
Rybak, Rachel
9
Wan, William
8
Gullen, Elizabeth
Sign-in to see all Coauthors
Publications
Sign-in to see all Publications
Sign in free and see...
Visualized networks:
See your personal network in
sophisticated graphical views
GeoTargeted Searches:
Locate experts around the world
and connect with global collaborators
Research Profiles:
See the visualized research activity
of experts around the globe
Sign-in to see more
Geonetwork of Earl Kern (preview)
Cities where this author has publications
Cities where co-authors of this author have publications
Sign-in to see more
All Publications
-
2009: Harden Emma A; Falshaw Ruth; Carnachan Susan M; Kern Earl R; Prichard Mark N
Virucidal activity of polysaccharide extracts from four algal species against herpes simplex virus.
Antiviral research 2009;83(3):282-9.
-
2009: Kern Earl R; Prichard Mark N; Quenelle Debra C; Keith Kathy A; Tiwari Kamal N; Maddry Joseph A; Secrist John A
Activities of certain 5-substituted 4'-thiopyrimidine nucleosides against orthopoxvirus infections.
Antimicrobial agents and chemotherapy 2009;53(2):572-9.
-
2008: Prichard Mark N; Hartline Caroll B; Harden Emma A; Daily Shannon L; Beadle James R; Valiaeva Nadejda; Kern Earl R; Hostetler Karl Y
Inhibition of herpesvirus replication by hexadecyloxypropyl esters of purine- and pyrimidine-based phosphonomethoxyethyl nucleoside phosphonates.
Antimicrobial agents and chemotherapy 2008;52(12):4326-30.
-
2008: Quenelle Debra C; Collins Deborah J; Rice Terri L; Prichard Mark N; Marciani Dante J; Kern Earl R
Effect of an immune enhancer, GPI-0100, on vaccination with live attenuated herpes simplex virus (HSV) type 2 or glycoprotein D on genital HSV-2 infections of guinea pigs.
Antiviral research 2008;80(2):223-4.
-
2008: Quenelle Debra C; Collins Deborah J; Pettway Latisha R; Hartline Caroll B; Beadle James R; Wan W Brad; Hostetler Karl Y; Kern Earl R
Effect of oral treatment with (S)-HPMPA, HDP-(S)-HPMPA or ODE-(S)-HPMPA on replication of murine cytomegalovirus (MCMV) or human cytomegalovirus (HCMV) in animal models.
Antiviral research 2008;79(2):133-5.
-
2008: Prichard Mark N; Sztul Elizabeth; Daily Shannon L; Perry Amie L; Frederick Samuel L; Gill Rachel B; Hartline Caroll B; Streblow Daniel N; Varnum Susan M; Smith Richard D; Kern Earl R
Human cytomegalovirus UL97 kinase activity is required for the hyperphosphorylation of retinoblastoma protein and inhibits the formation of nuclear aggresomes.
Journal of virology 2008;82(10):5054-67.
-
2008: Becker Marie N; Obraztsova Maria; Kern Earl R; Quenelle Debra C; Keith Kathy A; Prichard Mark N; Luo Ming; Moyer Richard W
Isolation and characterization of cidofovir resistant vaccinia viruses.
Virology journal 2008;5():58.
-
2008: Prichard Mark N; Kern Earl R; Quenelle Debra C; Keith Kathy A; Moyer Richard W; Turner Peter C
Vaccinia virus lacking the deoxyuridine triphosphatase gene (F2L) replicates well in vitro and in vivo, but is hypersensitive to the antiviral drug (N)-methanocarbathymidine.
Virology journal 2008;5():39.
-
2007: Quenelle Debra C; Collins Deborah J; Herrod Bridgett P; Keith Kathy A; Trahan Julissa; Beadle James R; Hostetler Karl Y; Kern Earl R
Effect of oral treatment with hexadecyloxypropyl-[(S)-9-(3-hydroxy-2- phosphonylmethoxypropyl)adenine] [(S)-HPMPA] or octadecyloxyethyl-(S)-HPMPA on cowpox or vaccinia virus infections in mice.
Antimicrobial agents and chemotherapy 2007;51(11):3940-7.
-
2007: Quenelle Debra C; Prichard Mark N; Keith Kathy A; Hruby Dennis E; Jordan Robert; Painter George R; Robertson Alice; Kern Earl R
Synergistic efficacy of the combination of ST-246 with CMX001 against orthopoxviruses.
Antimicrobial agents and chemotherapy 2007;51(11):4118-24.
-
2007: Prichard Mark N; Daily Shannon L; Jefferson Geraldine M; Perry Amie L; Kern Earl R
A rapid DNA hybridization assay for the evaluation of antiviral compounds against Epstein-Barr virus.
Journal of virological methods 2007;144(1-2):86-90.
-
2007: Ruiz Jacqueline C; Beadle James R; Aldern Kathy A; Keith Kathy A; Hartline Caroll B; Kern Earl R; Hostetler Karl Y
Synthesis and antiviral evaluation of alkoxyalkyl-phosphate conjugates of cidofovir and adefovir.
Antiviral research 2007;75(1):87-90.
-
2007: Prichard Mark N; Keith Kathy A; Johnson Mary P; Harden Emma A; McBrayer Alexis; Luo Ming; Qiu Shihong; Chattopadhyay Debasish; Fan Xuesen; Torrence Paul F; Kern Earl R
Selective phosphorylation of antiviral drugs by vaccinia virus thymidine kinase.
Antimicrobial agents and chemotherapy 2007;51(5):1795-803.
-
2007: Choo Hyunah; Beadle James R; Kern Earl R; Prichard Mark N; Keith Kathy A; Hartline Caroll B; Trahan Julissa; Aldern Kathy A; Korba Brent E; Hostetler Karl Y
Antiviral activities of novel 5-phosphono-pent-2-en-1-yl nucleosides and their alkoxyalkyl phosphonoesters.
Antimicrobial agents and chemotherapy 2007;51(2):611-5.
-
2007: Quenelle Debra C; Buller R M L; Parker Scott; Keith Kathy A; Hruby Dennis E; Jordan Robert; Kern Earl R
Efficacy of delayed treatment with ST-246 given orally against systemic orthopoxvirus infections in mice.
Antimicrobial agents and chemotherapy 2007;51(2):689-95.
-
2007: Zhou Shaoman; Zemlicka Jiri; Kern Earl R; Drach John C
Fluoroanalogues of anti-cytomegalovirus agent cyclopropavir: synthesis and antiviral activity of (E)- and (Z)-9-{[2,2-bis(hydroxymethyl)-3-fluorocyclopropylidene]methyl}-adenines and guanines.
Nucleosides, nucleotides & nucleic acids 2007;26(3):231-43.
-
2006: Zhou Shaoman; Kern Earl R; Gullen Elizabeth; Cheng Yung-Chi; Drach John C; Tamiya Sadahiro; Mitsuya Hiroaki; Zemlicka Jiri
9-{[3-fluoro-2-(hydroxymethyl)cyclopropylidene]methyl}adenines and -guanines. Synthesis and antiviral activity of all stereoisomers1.
Journal of medicinal chemistry 2006;49(20):6120-8.
-
2006: Kern Earl R
Pivotal role of animal models in the development of new therapies for cytomegalovirus infections.
Antiviral research 2006;71(2-3):164-71.
-
2006: Fan Xuesen; Zhang Xinying; Zhou Longhu; Keith Kathy A; Kern Earl R; Torrence Paul F
Assembling a smallpox biodefense by interrogating 5-substituted pyrimidine nucleoside chemical space.
Antiviral research 2006;71(2-3):201-5.
-
2006: Quenelle Debra C; Keith Kathy A; Kern Earl R
In vitro and in vivo evaluation of isatin-beta-thiosemicarbazone and marboran against vaccinia and cowpox virus infections.
Antiviral research 2006;71(1):24-30.
-
2006: Prichard Mark N; Williams Angela D; Keith Kathy A; Harden Emma A; Kern Earl R
Distinct thymidine kinases encoded by cowpox virus and herpes simplex virus contribute significantly to the differential antiviral activity of nucleoside analogs.
Antiviral research 2006;71(1):1-6.
-
2006: Fan Xuesen; Zhang Xinying; Zhou Longhu; Keith Kathy A; Prichard Mark N; Kern Earl R; Torrence Paul F
Toward orthopoxvirus countermeasures: a novel heteromorphic nucleoside of unusual structure.
Journal of medicinal chemistry 2006;49(14):4052-4.
-
2006: Fan Xuesen; Zhang Xinying; Zhou Longhu; Keith Kathy A; Kern Earl R; Torrence Paul F
5-(Dimethoxymethyl)-2'-deoxyuridine: a novel gem diether nucleoside with anti-orthopoxvirus activity.
Journal of medicinal chemistry 2006;49(11):3377-82.
-
2006: Fan Xuesen; Zhang Xinying; Zhou Longhu; Keith Kathy A; Kern Earl R; Torrence Paul F
A pyrimidine-pyrazolone nucleoside chimera with potent in vitro anti-orthopoxvirus activity.
Bioorganic & medicinal chemistry letters 2006;16(12):3224-8.
-
2006: Prichard Mark N; Keith Kathy A; Quenelle Debra C; Kern Earl R
Activity and mechanism of action of N-methanocarbathymidine against herpesvirus and orthopoxvirus infections.
Antimicrobial agents and chemotherapy 2006;50(4):1336-41.
-
2006: Beadle James R; Wan William B; Ciesla Stephanie L; Keith Kathy A; Hartline Caroll; Kern Earl R; Hostetler Karl Y
Synthesis and antiviral evaluation of alkoxyalkyl derivatives of 9-(S)-(3-hydroxy-2-phosphonomethoxypropyl)adenine against cytomegalovirus and orthopoxviruses.
Journal of medicinal chemistry 2006;49(6):2010-5.
-
2006: Quenelle Debra C; Collins Deborah J; Marciani Dante J; Kern Earl R
Effect of immunization with herpes simplex virus type-1 (HSV-1) glycoprotein D (gD) plus the immune enhancer GPI-0100 on infection with HSV-1 or HSV-2.
Vaccine 2006;24(10):1515-22.
-
2006: Parker Jacqueline N; Pfister Luz-Andrea; Quenelle Debra; Gillespie G Yancey; Markert James M; Kern Earl R; Whitley Richard J
Genetically engineered herpes simplex viruses that express IL-12 or GM-CSF as vaccine candidates.
Vaccine 2006;24(10):1644-52.
-
2006: Qin Xinrong; Chen Xinchao; Wang Kun; Polin Lisa; Kern Earl R; Drach John C; Gullen Elizabeth; Cheng Yung-Chi; Zemlicka Jiri
Synthesis, antiviral, and antitumor activity of 2-substituted purine methylenecyclopropane analogues of nucleosides.
Bioorganic & medicinal chemistry 2006;14(4):1247-54.
-
2006: Ruiz Jacqueline C; Aldern Kathy A; Beadle James R; Hartline Caroll B; Kern Earl R; Hostetler Karl Y
Synthesis and antiviral evaluation of alkoxyalkyl esters of phosphonopropoxymethyl-guanine and phosphonopropoxymethyl-diaminopurine.
Antiviral chemistry & chemotherapy 2006;17(2):89-95.
-
2006: Prichard Mark N; Quenelle Debra C; Bidanset Deborah J; Komazin Gloria; Chou Sunwen; Drach John C; Kern Earl R
Human cytomegalovirus UL27 is not required for viral replication in human tissue implanted in SCID mice.
Virology journal 2006;3():18.
-
2005: Prichard Mark N; Britt William J; Daily Shannon L; Hartline Caroll B; Kern Earl R
Human cytomegalovirus UL97 Kinase is required for the normal intranuclear distribution of pp65 and virion morphogenesis.
Journal of virology 2005;79(24):15494-502.
-
2005: Prichard Mark N; Kaiwar Ravi; Jackman Winthrop T; Quenelle Debra C; Collins Deborah J; Kern Earl R; Kemble George M; Spaete Richard R
Evaluation of AD472, a live attenuated recombinant herpes simplex virus type 2 vaccine in guinea pigs.
Vaccine 2005;23(46-47):5424-31.
-
2005: Williams-Aziz Stephanie L; Hartline Caroll B; Harden Emma A; Daily Shannon L; Prichard Mark N; Kushner Nicole L; Beadle James R; Wan W Brad; Hostetler Karl Y; Kern Earl R
Comparative activities of lipid esters of cidofovir and cyclic cidofovir against replication of herpesviruses in vitro.
Antimicrobial agents and chemotherapy 2005;49(9):3724-33.
-
2005: Kriesel John D; Spruance Spotswood L; Prichard Mark; Parker Jacqueline N; Kern Earl R
Recurrent antiviral-resistant genital herpes in an immunocompetent patient.
The Journal of infectious diseases 2005;192(1):156-61.
-
2005: Roy Atanu; Schneller Stewart W; Keith Kathy A; Hartline Caroll B; Kern Earl R
The 4',4'-difluoro analog of 5'-noraristeromycin: a new structural prototype for possible antiviral drug development toward orthopoxvirus and cytomegalovirus.
Bioorganic & medicinal chemistry 2005;13(14):4443-9.
-
2005: Prichard Mark N; Kern Earl R
Orthopoxvirus targets for the development of antiviral therapies.
Current drug targets. Infectious disorders 2005;5(1):17-28.
-
2005: Kern Earl R; Kushner Nicole L; Hartline Caroll B; Williams-Aziz Stephanie L; Harden Emma A; Zhou Shaoman; Zemlicka Jiri; Prichard Mark N
In vitro activity and mechanism of action of methylenecyclopropane analogs of nucleosides against herpesvirus replication.
Antimicrobial agents and chemotherapy 2005;49(3):1039-45.
-
2005: Hartline Caroll B; Harden Emma A; Williams-Aziz Stephanie L; Kushner Nicole L; Brideau Roger J; Kern Earl R
Inhibition of herpesvirus replication by a series of 4-oxo-dihydroquinolines with viral polymerase activity.
Antiviral research 2005;65(2):97-105.
-
2005: Wan William B; Beadle James R; Hartline Caroll; Kern Earl R; Ciesla Stephanie L; Valiaeva Nadejda; Hostetler Karl Y
Comparison of the antiviral activities of alkoxyalkyl and alkyl esters of cidofovir against human and murine cytomegalovirus replication in vitro.
Antimicrobial agents and chemotherapy 2005;49(2):656-62.
-
2005: Hartline Caroll B; Gustin Kortney M; Wan William B; Ciesla Stephanie L; Beadle James R; Hostetler Karl Y; Kern Earl R
Ether lipid-ester prodrugs of acyclic nucleoside phosphonates: activity against adenovirus replication in vitro.
The Journal of infectious diseases 2005;191(3):396-9.
-
2005: Yan Zhaohua; Kern Earl R; Gullen Elizabeth; Cheng Yung-Chi; Drach John C; Zemlicka Jiri
Nucleotides and pronucleotides of 2,2-bis(hydroxymethyl)methylenecyclopropane analogues of purine nucleosides: synthesis and antiviral activity.
Journal of medicinal chemistry 2005;48(1):91-9.
-
2005: Ambrose Amalraj; Zemlicka Jiri; Kern Earl R; Drach John C; Gullen Elizabeth; Cheng Yung-Chi
Phosphoralaninate pronucleotides of pyrimidine methylenecyclopropane analogues of nucleosides: synthesis and antiviral activity.
Nucleosides, nucleotides & nucleic acids 2005;24(10-12):1763-74.
-
2005: Zhou Longhu; Amer Adel; Korn Michael; Burda Robert; Balzarini Jan; De Clercq Erik; Kern Earl R; Torrence Paul F
Synthesis and antiviral activities of 1,2,3-triazole functionalized thymidines: 1,3-dipolar cycloaddition for efficient regioselective diversity generation.
Antiviral chemistry & chemotherapy 2005;16(6):375-83.
-
2005: Prichard Mark N; Lawlor Heather; Duke Gregory M; Mo Chengjun; Wang Zhaoti; Dixon Melissa; Kemble George; Kern Earl R
Human cytomegalovirus uracil DNA glycosylase associates with ppUL44 and accelerates the accumulation of viral DNA.
Virology journal 2005;2():55.
-
2004: Zhou Shaoman; Kern Earl R; Gullen Elizabeth; Cheng Yung-Chi; Drach John C; Matsumi Shintaro; Mitsuya Hiroaki; Zemlicka Jiri
(Z)- and (E)-[2-Fluoro-2-(hydroxymethyl)cyclopropylidene]methylpurines and -pyrimidines, a new class of methylenecyclopropane analogues of nucleosides: synthesis and antiviral activity.
Journal of medicinal chemistry 2004;47(27):6964-72.
-
2004: Kern Earl R; Bidanset Deborah J; Hartline Caroll B; Yan Zhaohua; Zemlicka Jiri; Quenelle Debra C
Oral activity of a methylenecyclopropane analog, cyclopropavir, in animal models for cytomegalovirus infections.
Antimicrobial agents and chemotherapy 2004;48(12):4745-53.
-
2004: Kern Earl R; Collins Deborah J; Wan W Brad; Beadle James R; Hostetler Karl Y; Quenelle Debra C
Oral treatment of murine cytomegalovirus infections with ether lipid esters of cidofovir.
Antimicrobial agents and chemotherapy 2004;48(9):3516-22.
-
2004: Bidanset Deborah J; Beadle James R; Wan W Brad; Hostetler Karl Y; Kern Earl R
Oral activity of ether lipid ester prodrugs of cidofovir against experimental human cytomegalovirus infection.
The Journal of infectious diseases 2004;190(3):499-503.
-
2004: Bidanset Deborah J; Rybak Rachel J; Hartline Caroll B; Kern Earl R
Efficacy of ganciclovir and cidofovir against human cytomegalovirus replication in SCID mice implanted with human retinal tissue.
Antiviral research 2004;63(1):61-4.
-
2004: Quenelle Debra C; Collins Deborah J; Kern Earl R
Cutaneous infections of mice with vaccinia or cowpox viruses and efficacy of cidofovir.
Antiviral research 2004;63(1):33-40.
-
2004: Keith Kathy A; Wan William B; Ciesla Stephanie L; Beadle James R; Hostetler Karl Y; Kern Earl R
Inhibitory activity of alkoxyalkyl and alkyl esters of cidofovir and cyclic cidofovir against orthopoxvirus replication in vitro.
Antimicrobial agents and chemotherapy 2004;48(5):1869-71.
-
2004: Kern Earl R; Hartline Caroll B; Rybak Rachel J; Drach John C; Townsend Leroy B; Biron Karen K; Bidanset Deborah J
Activities of benzimidazole D- and L-ribonucleosides in animal models of cytomegalovirus infections.
Antimicrobial agents and chemotherapy 2004;48(5):1749-55.
-
2004: Quenelle Debra C; Collins Deborah J; Wan W Brad; Beadle James R; Hostetler Karl Y; Kern Earl R
Oral treatment of cowpox and vaccinia virus infections in mice with ether lipid esters of cidofovir.
Antimicrobial agents and chemotherapy 2004;48(2):404-12.
-
2004: Zhou Shaoman; Breitenbach Julie M; Borysko Katherine Z; Drach John C; Kern Earl R; Gullen Elizabeth; Cheng Yung-Chi; Zemlicka Jiri
Synthesis and antiviral activity of (Z)- and (E)-2,2-[bis(hydroxymethyl)cyclopropylidene]methylpurines and -pyrimidines: second-generation methylenecyclopropane analogues of nucleosides.
Journal of medicinal chemistry 2004;47(3):566-75.
-
2003: Kushner Nicole L; Williams Stephanie L; Hartline Caroll B; Harden Emma A; Bidanset Deborah J; Chen Xinchao; Zemlicka Jiri; Kern Earl R
Efficacy of methylenecyclopropane analogs of nucleosides against herpesvirus replication in vitro.
Nucleosides, nucleotides & nucleic acids 2003;22(12):2105-19.
-
2003: Quenelle Debra C; Collins Deborah J; Kern Earl R
Efficacy of multiple- or single-dose cidofovir against vaccinia and cowpox virus infections in mice.
Antimicrobial agents and chemotherapy 2003;47(10):3275-80.
-
2003: Keith Kathy A; Hitchcock Michael J M; Lee William A; Holý Antonin; Kern Earl R
Evaluation of nucleoside phosphonates and their analogs and prodrugs for inhibition of orthopoxvirus replication.
Antimicrobial agents and chemotherapy 2003;47(7):2193-8.
-
2003: Williams Stephanie L; Hartline Caroll B; Kushner Nicole L; Harden Emma A; Bidanset Deborah J; Drach John C; Townsend Leroy B; Underwood Mark R; Biron Karen K; Kern Earl R
In vitro activities of benzimidazole D- and L-ribonucleosides against herpesviruses.
Antimicrobial agents and chemotherapy 2003;47(7):2186-92.
-
2003: Wang Ruifang; Chen Xinchao; Drach John C; Kern Earl R; Zemlicka Jiri
Synthesis and biological activity of 2-aminopurine methylenecyclopropane analogues of nucleosides.
Nucleosides, nucleotides & nucleic acids 2003;22(5-8):813-5.
-
2003: Temperton Nigel J; Quenelle Debra C; Lawson Keirissa M; Zuckerman Jane N; Kern Earl R; Griffiths Paul D; Emery Vincent C
Enhancement of humoral immune responses to a human cytomegalovirus DNA vaccine: adjuvant effects of aluminum phosphate and CpG oligodeoxynucleotides.
Journal of medical virology 2003;70(1):86-90.
-
2003: Long Mary C; Bidanset Deborah J; Williams Stephanie L; Kushner Nicole L; Kern Earl R
Determination of antiviral efficacy against lymphotropic herpesviruses utilizing flow cytometry.
Antiviral research 2003;58(2):149-57.
-
2003: Chen Xinchao; Kern Earl R; Drach John C; Gullen Elizabeth; Cheng Yung-Chi; Zemlicka Jiri
Structure-activity relationships of (S,Z)-2-aminopurine methylenecyclopropane analogues of nucleosides. Variation of purine-6 substituents and activity against herpesviruses and hepatitis B virus.
Journal of medicinal chemistry 2003;46(8):1531-7.
-
2003: Wang Ruifang; Chen Xinchao; Drach John C; Kern Earl R; Zemlicka Jiri
Synthesis and biological activity of 2-aminopurine methylenecyclopropane analogues of nucleosides.
Nucleosides, nucleotides & nucleic acids 2003;22(2):135-44.
-
2003: Kern Earl R
In vitro activity of potential anti-poxvirus agents.
Antiviral research 2003;57(1-2):35-40.
-
2002: Wang Ruifang; Corbett Thomas H; Cheng Yung-Chi; Drach John C; Kern Earl R; Mitsuya Hiroaki; Zemlicka Jiri
Tryptophanyl phosphoramidates as prodrugs of synadenol and its E-isomer: synthesis and biological activity.
Bioorganic & medicinal chemistry letters 2002;12(17):2467-70.
-
2002: Beadle James R; Hartline Caroll; Aldern Kathy A; Rodriguez Natalie; Harden Emma; Kern Earl R; Hostetler Karl Y
Alkoxyalkyl esters of cidofovir and cyclic cidofovir exhibit multiple-log enhancement of antiviral activity against cytomegalovirus and herpesvirus replication in vitro.
Antimicrobial agents and chemotherapy 2002;46(8):2381-6.
-
2002: Wang Ruifang; Kern Earl R; Zemlicka Jiri
Synthesis of methylenecyclobutane analogues of nucleosides with axial chirality and their phosphoralaninates: a new pronucleotide effective against Epstein-Barr virus.
Antiviral chemistry & chemotherapy 2002;13(4):251-62.
-
2002: Kern Earl R; Hartline Caroll; Harden Emma; Keith Kathy; Rodriguez Natalie; Beadle James R; Hostetler Karl Y
Enhanced inhibition of orthopoxvirus replication in vitro by alkoxyalkyl esters of cidofovir and cyclic cidofovir.
Antimicrobial agents and chemotherapy 2002;46(4):991-5.
-
2002: Rajappan Vasanthakumar; Schneller Stewart W; Williams Stephanie L; Kern Earl R
The enantiomers of carbocyclic 5'-norguanosine: activity towards Epstein-Barr virus.
Bioorganic & medicinal chemistry 2002;10(4):883-6.
-
2001: Wang R; Ksebati M B; Corbett T H; Kern E R; Drach J C; Zemlicka J
Methylene-gem-difluorocyclopropane analogues of nucleosides: synthesis, cyclopropene-methylenecyclopropane rearrangement, and biological activity.
Journal of medicinal chemistry 2001;44(23):4019-22.
-
2001: Bidanset D J; Placidi L; Rybak R; Palmer J; Sommadossi J P; Kern E R
Intravenous infusion of cereport increases uptake and efficacy of acyclovir in herpes simplex virus-infected rat brains.
Antimicrobial agents and chemotherapy 2001;45(8):2316-23.
-
2001: Bidanset D J; Rybak R J; Hartline C B; Kern E R
Replication of human cytomegalovirus in severe combined immunodeficient mice implanted with human retinal tissue.
The Journal of infectious diseases 2001;184(2):192-5.
-
2001: Hostetler K Y; Rybak R J; Beadle J R; Gardner M F; Aldern K A; Wright K N; Kern E R
In vitro and in vivo activity of 1-O-hexadecylpropanediol-3-phospho-ganciclovir and 1-O-hexadecylpropanediol-3-phospho-penciclovir in cytomegalovirus and herpes simplex virus infections.
Antiviral chemistry & chemotherapy 2001;12(1):61-70.
-
2001: Kern E R; Rybak R J; Hartline C B; Bidanset D J
Predictive efficacy of SCID-hu mouse models for treatment of human cytomegalovirus infections.
Antiviral chemistry & chemotherapy 2001;12 Suppl 1():149-56.
-
2000: Guan H P; Ksebati M B; Kern E R; Zemlicka J
Approaches to unsaturated analogues of nucleosides comprising four- and six-membered rings.
The Journal of organic chemistry 2000;65(17):5177-84.
-
2000: Rybak R J; Hartline C B; Qiu Y L; Zemlicka J; Harden E; Marshall G; Sommadossi J P; Kern E R
In vitro activities of methylenecyclopropane analogues of nucleosides and their phosphoralaninate prodrugs against cytomegalovirus and other herpesvirus infections.
Antimicrobial agents and chemotherapy 2000;44(6):1506-11.
-
2000: Qiu Y L; Geiser F; Kira T; Gullen E; Cheng Y C; Ptak R G; Breitenbach J M; Drach J C; Hartline C B; Kern E R; Zemlicka J
Synthesis and enantioselectivity of the antiviral effects of (R,Z)-,(S,Z)-methylenecyclopropane analogues of purine nucleosides and phosphoralaninate prodrugs: influence of heterocyclic base, type of virus and host cells.
Antiviral chemistry & chemotherapy 2000;11(3):191-202.
-
2000: Guan H P; Ksebati M B; Cheng Y C; Drach J C; Kern E R; Zemlicka J
Spiropentane mimics of nucleosides: analogues of 2'-deoxyadenosine and 2'-deoxyguanosine. Synthesis of all stereoisomers, isomeric assignment, and biological activity.
The Journal of organic chemistry 2000;65(5):1280-90.
-
2000: Kern E R; Palmer J; Szczech G; Painter G; Hostetler K Y
Efficacy of topical acyclovir monophosphate, acyclovir, or penciclovir in orofacial HSV-1 infections of mice and genital HSV-2 infections of guinea pigs.
Nucleosides, nucleotides & nucleic acids 2000;19(1-2):501-13.
-
2000: Beadle J R; Kini G D; Aldern K A; Gardner M F; Wright K N; Rybak R J; Kern E R; Hostetler K Y
Synthesis and antiviral evaluation of 1-O-hexadecylpropanediol-3-P-acyclovir: efficacy against HSV-1 infection in mice.
Nucleosides, nucleotides & nucleic acids 2000;19(1-2):471-9.
-
1999: Rybak R J; Zemlicka J; Qiu Y L; Hartline C B; Kern E R
Effective treatment of murine cytomegalovirus infections with methylenecyclopropane analogues of nucleosides.
Antiviral research 1999;43(3):175-88.
-
1999: Qiu Y L; Ptak R G; Breitenbach J M; Lin J S; Cheng Y C; Drach J C; Kern E R; Zemlicka J
Synthesis and antiviral activity of phosphoralaninate derivatives of methylenecyclopropane analogues of nucleosides.
Antiviral research 1999;43(1):37-53.
-
1999: Afouna M I; Mehta S C; Ghanem A H; Higuchi W I; Kern E R; DeClercq E; El-Shattawy H H
Influence of the treatment protocol upon the in vivo efficacy of cidofovir (HPMPC) and of acyclovir (ACV) formulations in topical treatment of cutaneous HSV-1 infection in hairless mice.
Journal of pharmaceutical sciences 1999;88(5):530-4.
-
1998: Afouna M I; Mehta S C; Ghanem A H; Higuchi W I; Kern E R; De Clercq E; El-Shattawy H H
Assessment of correlation between skin target site free drug concentration and the in vivo topical antiviral efficacy in hairless mice for (E)-5-(2-bromovinyl)-2'-deoxyuridine and acyclovir formulations.
Journal of pharmaceutical sciences 1998;87(8):917-21.
-
1998: Qiu Y L; Ptak R G; Breitenbach J M; Lin J S; Cheng Y C; Kern E R; Drach J C; Zemlicka J
(Z)- and (E)-2-(hydroxymethylcyclopropylidene)-methylpurines and pyrimidines as antiviral agents.
Antiviral chemistry & chemotherapy 1998;9(4):341-52.
-
1998: Spector F C; Kern E R; Palmer J; Kaiwar R; Cha T A; Brown P; Spaete R R
Evaluation of a live attenuated recombinant virus RAV 9395 as a herpes simplex virus type 2 vaccine in guinea pigs.
The Journal of infectious diseases 1998;177(5):1143-54.
-
1998: Qiu Y L; Ksebati M B; Ptak R G; Fan B Y; Breitenbach J M; Lin J S; Cheng Y C; Kern E R; Drach J C; Zemlicka J
(Z)- and (E)-2-((hydroxymethyl)cyclopropylidene)methyladenine and -guanine. New nucleoside analogues with a broad-spectrum antiviral activity.
Journal of medicinal chemistry 1998;41(1):10-23.
-
1997: Mehta S C; Afouna M I; Ghanem A H; Higuchi W I; Kern E R
Relationship of skin target site free drug concentration (C*) to the in vivo efficacy: an extensive evaluation of the predictive value of the C* concept using acyclovir as a model drug.
Journal of pharmaceutical sciences 1997;86(7):797-801.
-
1996: Patel P J; Ghanem A H; Higuchi W I; Srinivasan V; Kern E R
Correlation of in vivo topical efficacies with in vitro predictions using acyclovir formulations in the treatment of cutaneous HSV-1 infections in hairless mice: an evaluation of the predictive value of the C* concept.
Antiviral research 1996;29(2-3):279-86.
-
1996: Kern E R
Role of animal models in selecting antiviral combinations for clinical studies.
Antiviral research 1996;29(1):57-9.
-
1995: Krawczyk S H; Nassiri M R; Kucera L S; Kern E R; Ptak R G; Wotring L L; Drach J C; Townsend L B
Synthesis and antiproliferative and antiviral activity of 2'-deoxy-2'-fluoroarabinofuranosyl analogs of the nucleoside antibiotics toyocamycin and sangivamycin.
Journal of medicinal chemistry 1995;38(20):4106-14.
-
1995: Kimberlin D W; Kern E R; Sidwell R W; North T W; Whitley R J
Models of antiviral resistance.
Antiviral research 1995;26(4):415-22.
-
1994: Imanidis G; Song W Q; Lee P H; Su M H; Kern E R; Higuchi W I
Estimation of skin target site acyclovir concentrations following controlled (trans)dermal drug delivery in topical and systemic treatment of cutaneous HSV-1 infections in hairless mice.
Pharmaceutical research 1994;11(7):1035-41.
-
1993: Whitley R J; Kern E R; Chatterjee S; Chou J; Roizman B
Replication, establishment of latency, and induced reactivation of herpes simplex virus gamma 1 34.5 deletion mutants in rodent models.
The Journal of clinical investigation 1993;91(6):2837-43.
-
1992: Chatterjee S; Burns P; Whitley R J; Kern E R
Effect of (S)-1-[(3-hydroxy-2-phosphonyl methoxy) propyl] cytosine on the replication and morphogenesis of herpes simplex virus type 1.
Antiviral research 1992;19(3):181-92.
-
1992: Lee P H; Su M H; Kern E R; Higuchi W I
Novel animal model for evaluating topical efficacy of antiviral agents: flux versus efficacy correlations in the acyclovir treatment of cutaneous herpes simplex virus type 1 (HSV-1) infections in hairless mice.
Pharmaceutical research 1992;9(8):979-89.
-
1992: Renau T E; Nassiri M R; Swayze E E; Kern E R; Townsend L B; Drach J C
Improved synthesis and biological evaluation of an acyclic thiosangivamycin active against human cytomegalovirus.
Antiviral research 1992;19(1):15-28.
-
1991: Kern E R
Value of animal models to evaluate agents with potential activity against human cytomegalovirus.
Transplantation proceedings 1991;23(3 Suppl 3):152-5, discussion 155.
-
1991: Shao Y L; Shelby J; Hisatake G; Kern E R; Nelson E W; Gay W A
Accelerated cardiac allograft rejection in murine cytomegalovirus-infected C3H recipients.
Transplantation proceedings 1991;23(1 Pt 1):129-30.
-
1990: Krawczyk S H; Bernier-Rodriguez M; Nassiri M R; Kern E R; Wotring L L; Drach J C; Townsend L B
Arabinofuranosylpyrrolo[2,3-d]pyrimidines as potential agents for human cytomegalovirus infections.
Journal of medicinal chemistry 1990;33(12):3160-9.
-
1990: Pudlo J S; Nassiri M R; Kern E R; Wotring L L; Drach J C; Townsend L B
Synthesis, antiproliferative, and antiviral activity of certain 4-substituted and 4,5-disubstituted 7-[(1,3-dihydroxy-2-propoxy)methyl]pyrrolo[2,3-d]pyrimidines.
Journal of medicinal chemistry 1990;33(7):1984-92.
-
1989: Shelby J; Saffle J R; Kern E R
Delayed type hypersensitivity (DTH) response and skin graft survival in 9-(1, 3-dihydroxy-2-propoxymethyl) guanine (DHPG) treated mice.
Transplantation proceedings 1989;21(1 Pt 1):1150-1.
Sign-in to see more